vs
NEKTAR THERAPEUTICS（NKTR）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是NEKTAR THERAPEUTICS的2.0倍（$43.2M vs $21.8M），万物新生净利率更高（16.9% vs -165.4%，领先182.3%）
内克塔医疗是一家美国生物制药企业，1990年成立，总部位于加利福尼亚州旧金山。该企业依托专有的聚乙二醇化技术与先进高分子偶联技术，通过改性物质化学结构研发候选新药，可改善药物滞留性、溶解度等特性，同时也是安进、默克、辉瑞等多家知名药企的技术供应商。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
NKTR vs RERE — 直观对比
营收规模更大
RERE
是对方的2.0倍
$21.8M
净利率更高
RERE
高出182.3%
-165.4%
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $21.8M | $43.2M |
| 净利润 | $-36.1M | $7.3M |
| 毛利率 | — | — |
| 营业利润率 | -126.9% | — |
| 净利率 | -165.4% | 16.9% |
| 营收同比 | -25.3% | — |
| 净利润同比 | -596.9% | — |
| 每股收益（稀释后） | $-4.67 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NKTRRERE
| Q4 25 | $21.8M | — | ||
| Q3 25 | $11.8M | — | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $10.5M | — | ||
| Q4 24 | $29.2M | — | ||
| Q3 24 | $24.1M | — | ||
| Q2 24 | $23.5M | — | ||
| Q1 24 | $21.6M | — |
净利润NKTRRERE
| Q4 25 | $-36.1M | — | ||
| Q3 25 | $-35.5M | — | ||
| Q2 25 | $-41.6M | — | ||
| Q1 25 | $-50.9M | — | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $-37.1M | — | ||
| Q2 24 | $-52.4M | — | ||
| Q1 24 | $-36.8M | — |
毛利率NKTRRERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 72.7% | — | ||
| Q3 24 | 81.6% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 60.6% | — |
营业利润率NKTRRERE
| Q4 25 | -126.9% | — | ||
| Q3 25 | -268.6% | — | ||
| Q2 25 | -324.2% | — | ||
| Q1 25 | -425.8% | — | ||
| Q4 24 | 49.2% | — | ||
| Q3 24 | -142.4% | — | ||
| Q2 24 | -211.9% | — | ||
| Q1 24 | -163.7% | — |
净利率NKTRRERE
| Q4 25 | -165.4% | — | ||
| Q3 25 | -301.3% | — | ||
| Q2 25 | -372.2% | — | ||
| Q1 25 | -486.4% | — | ||
| Q4 24 | 24.9% | — | ||
| Q3 24 | -153.6% | — | ||
| Q2 24 | -222.9% | — | ||
| Q1 24 | -170.1% | — |
每股收益（稀释后）NKTRRERE
| Q4 25 | $-4.67 | — | ||
| Q3 25 | $-1.87 | — | ||
| Q2 25 | $-2.95 | — | ||
| Q1 25 | $-0.24 | — | ||
| Q4 24 | $-2.07 | — | ||
| Q3 24 | $-2.66 | — | ||
| Q2 24 | $-3.76 | — | ||
| Q1 24 | $-0.19 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.1M | $228.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $89.8M | $557.1M |
| 总资产 | $280.4M | $722.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NKTRRERE
| Q4 25 | $15.1M | — | ||
| Q3 25 | $41.0M | — | ||
| Q2 25 | $43.0M | — | ||
| Q1 25 | $38.9M | — | ||
| Q4 24 | $44.3M | — | ||
| Q3 24 | $30.1M | — | ||
| Q2 24 | $27.9M | — | ||
| Q1 24 | $48.6M | — |
股东权益NKTRRERE
| Q4 25 | $89.8M | — | ||
| Q3 25 | $85.1M | — | ||
| Q2 25 | $-24.2M | — | ||
| Q1 25 | $13.7M | — | ||
| Q4 24 | $60.7M | — | ||
| Q3 24 | $48.9M | — | ||
| Q2 24 | $79.7M | — | ||
| Q1 24 | $126.7M | — |
总资产NKTRRERE
| Q4 25 | $280.4M | — | ||
| Q3 25 | $301.3M | — | ||
| Q2 25 | $207.5M | — | ||
| Q1 25 | $256.2M | — | ||
| Q4 24 | $303.9M | — | ||
| Q3 24 | $308.0M | — | ||
| Q2 24 | $343.3M | — | ||
| Q1 24 | $396.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-65.0M | — |
| 自由现金流率自由现金流/营收 | -298.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-208.7M | — |
8季度趋势，按日历期对齐
经营现金流NKTRRERE
| Q4 25 | $-65.0M | — | ||
| Q3 25 | $-48.8M | — | ||
| Q2 25 | $-45.7M | — | ||
| Q1 25 | $-49.1M | — | ||
| Q4 24 | $-46.2M | — | ||
| Q3 24 | $-43.9M | — | ||
| Q2 24 | $-37.7M | — | ||
| Q1 24 | $-47.9M | — |
自由现金流NKTRRERE
| Q4 25 | $-65.0M | — | ||
| Q3 25 | $-48.9M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-49.1M | — | ||
| Q4 24 | $-46.6M | — | ||
| Q3 24 | $-44.6M | — | ||
| Q2 24 | $-37.9M | — | ||
| Q1 24 | $-48.0M | — |
自由现金流率NKTRRERE
| Q4 25 | -298.0% | — | ||
| Q3 25 | -414.5% | — | ||
| Q2 25 | -409.6% | — | ||
| Q1 25 | -469.0% | — | ||
| Q4 24 | -159.9% | — | ||
| Q3 24 | -184.9% | — | ||
| Q2 24 | -161.3% | — | ||
| Q1 24 | -222.0% | — |
资本支出强度NKTRRERE
| Q4 25 | 0.1% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.7% | — |
现金转化率NKTRRERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -6.36× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
